Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy E Schade

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Nucleic Acids Research|November 1, 2019
RB, p130 and p107 differentially repress G1/S and G2/M genes after p53 activationAmy E Schade, Martin Fischer, James A DeCaprio
Oncogene|March 6, 2019
Cyclin D-CDK4 relieves cooperative repression of proliferation and cell cycle gene expression by DREAM and RBAmy E Schade, Matthew G Oser, Hilary E Nicholson, et al.
Trends in Biochemical Sciences|July 14, 2022
Coordinating gene expression during the cell cycleMartin Fischer, Amy E Schade, Timothy B Branigan, et al.
Plos Biology|April 27, 2023
Combating castration-resistant prostate cancer by co-targeting the epigenetic regulators EZH2 and HDACAmy E Schade, Ryan Kuzmickas, Carrie L Rodriguez, et al.
Cell Reports|March 3, 2021
MMB-FOXM1-driven premature mitosis is required for CHK1 inhibitor sensitivityTimothy B Branigan, David Kozono, Amy E Schade, et al.
Cancer Research|January 6, 2026
EZH2 Inhibitors Sensitize Breast Cancer to HER2 Kinase Inhibitors through Cooperative Effects on YAP and Pro-apoptotic RegulatorsNaiara Perurena, Marina Watanabe, Amy E Schade, et al.
The Journal of Clinical Investigation|June 29, 2023
Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancerFrancesca Nardi, Naiara Perurena, Amy E Schade, et al.
Elife|January 9, 2020
STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cellsJong Wook Kim, Christian Berrios, Miju Kim, et al.
The Journal of Clinical Investigation|June 9, 2026
Epigenetic and oncogenic inhibitors converge to drive a metabolic catastrophe in castration-resistant prostate cancerRhea Sahu, Miriam Enos, Swastika Sharma, et al.
Cancer Discovery|August 9, 2024
Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal CancersPatrick Loi, Amy E Schade, Carrie L Rodriguez, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nucleic Acids Research|November 1, 2019
RB, p130 and p107 differentially repress G1/S and G2/M genes after p53 activationAmy E Schade, Martin Fischer, James A DeCaprio
Oncogene|March 6, 2019
Cyclin D-CDK4 relieves cooperative repression of proliferation and cell cycle gene expression by DREAM and RBAmy E Schade, Matthew G Oser, Hilary E Nicholson, et al.
Trends in Biochemical Sciences|July 14, 2022
Coordinating gene expression during the cell cycleMartin Fischer, Amy E Schade, Timothy B Branigan, et al.
Plos Biology|April 27, 2023
Combating castration-resistant prostate cancer by co-targeting the epigenetic regulators EZH2 and HDACAmy E Schade, Ryan Kuzmickas, Carrie L Rodriguez, et al.
Cell Reports|March 3, 2021
MMB-FOXM1-driven premature mitosis is required for CHK1 inhibitor sensitivityTimothy B Branigan, David Kozono, Amy E Schade, et al.
Cancer Research|January 6, 2026
EZH2 Inhibitors Sensitize Breast Cancer to HER2 Kinase Inhibitors through Cooperative Effects on YAP and Pro-apoptotic RegulatorsNaiara Perurena, Marina Watanabe, Amy E Schade, et al.
The Journal of Clinical Investigation|June 29, 2023
Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancerFrancesca Nardi, Naiara Perurena, Amy E Schade, et al.
Elife|January 9, 2020
STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cellsJong Wook Kim, Christian Berrios, Miju Kim, et al.
The Journal of Clinical Investigation|June 9, 2026
Epigenetic and oncogenic inhibitors converge to drive a metabolic catastrophe in castration-resistant prostate cancerRhea Sahu, Miriam Enos, Swastika Sharma, et al.
Cancer Discovery|August 9, 2024
Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal CancersPatrick Loi, Amy E Schade, Carrie L Rodriguez, et al.
Pageof 2